Therapeutic Options for Modifying Obesity and Cardiometabolic Risk Factors Louis J. Aronne Kathy Keenan Isoldi Dennis T. Roarke Excess fat mass is associated with an increased risk of developing a…
Pharmacologic Treatment of Dyslipidemia and Cardiovascular Disease Jennifer G. Robinson Extensive animal and clinical trial evidence has shown that lowering low-density lipoprotein cholesterol (LDL-C) slows the development of atherosclerotic disease…
Effect of Exercise on Dyslipidemia Mary P. McGowan The profound benefits of regular physical activity (PA) cannot be disputed. Individuals who engage in the regular expenditure of energy whether as…
Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease Harold E. Bays Elevated triglycerides (TG) are a risk factor for cardiovascular disease (CVD). Severe hypertriglyceridemia can cause pancreatitis. Fish…
Trans Fatty Acids, Dyslipidemia, and Cardiovascular Disease Edmond K. Kabagambe Frank A. Franklin Trans fatty acids are unsaturated fatty acids in which the hydrogen molecules at one or more of…
Dietary Treatment of Dyslipidemia Virginia W. Hartmuller Extensive evidence exists from population studies and clinical trials for the association between many dietary factors and blood lipid levels and the risk…
Lipoprotein (A): A Pleotropic Risk Factor for Cardiovascular Disease Ernst J. Schaefer Mary E. Herman Jennifer J. Jenner Leo J. Seman In this chapter we review the current state of…
Other Nontraditional Risk Factors for Cardiovascular Disease Simeon Margolis It is relatively easy to decide how aggressively to pursue preventive measures in people at low risk (no risk factors) and…
Apob and the Atherogenic Apob Dyslipoproteinemias Allan D. Sniderman Jacqueline P. De Graaf Patrick Couture Vascular disease remains the greatest cause of death in the developed countries and has reached…
Clinical Utility of Inflammatory Markers Kiran Musunuru Samia Mora High-sensitivity C-reactive protein (hsCRP) testing is inexpensive and has been shown to (a) predict cardiovascular risk in multiple patient groups; (b)…
